Literature DB >> 5890664

[Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures].

A Mayr, E Munz.   

Abstract

Entities:  

Mesh：

Year:  1964        PMID： 5890664

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Orig        ISSN： 0372-8110


× No keyword cloud information.
  30 in total

1.  Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.

Authors:  Kaïdre Bendjama; Eric Quemeneur
Journal:  Hum Vaccin Immunother       Date:  2017-08-28       Impact factor: 3.452

2.  Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.

Authors:  Sharone Green; Francis A Ennis; Anuja Mathew
Journal:  Vaccine       Date:  2010-12-31       Impact factor: 3.641

3.  Pattern Recognition Receptors of Nucleic Acids Can Cause Sublethal Activation of the Mitochondrial Apoptosis Pathway during Viral Infection.

Authors:  Sylwia Gradzka-Boberda; Ian E Gentle; Georg Häcker
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

4.  Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.

Authors:  Fei Song; Robert Fux; Lisette B Provacia; Asisa Volz; Markus Eickmann; Stephan Becker; Albert D M E Osterhaus; Bart L Haagmans; Gerd Sutter
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

5.  Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.

Authors:  Sharon E Frey; Patricia L Winokur; Robert A Salata; Samer S El-Kamary; Christine B Turley; Emmanuel B Walter; Christine Mhorag Hay; Frances K Newman; Heather R Hill; Ying Zhang; Paul Chaplin; Magdalena Tary-Lehmann; Robert B Belshe
Journal:  Vaccine       Date:  2013-05-09       Impact factor: 3.641

Review 6.  Novel viral vectored vaccines for the prevention of influenza.

Authors:  Teresa Lambe
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

7.  Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation.

Authors:  Laura E McCoy; Aodhnait S Fahy; Ron A-J Chen; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2010-05-05       Impact factor: 3.891

8.  Authentication of the R06E fruit bat cell line.

Authors:  Ingo Jordan; Vincent J Munster; Volker Sandig
Journal:  Viruses       Date:  2012-05-23       Impact factor: 5.048

9.  Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Authors:  Claire M Midgley; Mike M Putz; Jonathan N Weber; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

10.  A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Authors:  Ingo Jordan; Deborah Horn; Katrin John; Volker Sandig
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.